MTNB Stock Analysis: Buy, Sell, or Hold?
MTNB - Matinas BioPharma Holdings, Inc.
$0.20
0.02 (8.93%)
▲
5d:
-15.04%
30d:
-20.22%
90d:
-70.32%
WAIT
LOW Confidence
Analysis Updated: Aug 21, 2026 12:00 AM ET
Earnings: Aug 13, 2026
0d
Get Alerted When MTNB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: MTNB is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: MTNB is down 15.0% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MTNB is currently trading at $0.20, which is considered oversold relative to its 30-day fair value range of $0.22 to $0.34.
Technical Outlook: Technically, MTNB is in a downtrend. Immediate support is located at $0.18, while resistance sits at $0.28. The stock is showing strong short-term momentum, up 8.9% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+14990.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MTNB is in a downtrend. Immediate support is located at $0.18, while resistance sits at $0.28. The stock is showing strong short-term momentum, up 8.9% recently.
Market Sentiment: The stock scores a mixed 48/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $30.00 (+14990.5%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$0.22 -
$0.34
Company Quality Score
50/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
82.6%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (48/100)
- BULLISH: Strong upward momentum (+8.9%)
- BULLISH: Trading 14990.5% below Wall St target ($30.00)
- WARNING: Composite score 50/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$0.22 -
$0.34
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$0.18
Resistance Level
$0.28
Current Trend
Downtrend
Technical data as of
Aug 21, 2026
Fundamental Context
Wall Street Target
$30.00
(+14990.5%)
Revenue Growth (YoY)
-100.0%
Share & Embed Analysis
Last updated: August 24, 2026 8:45 AM ET
Data refreshes hourly during market hours. Next update: 9:45 AM
Data refreshes hourly during market hours. Next update: 9:45 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MTNB showing a specific setup today?
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$370 | 42 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$433 | 27 SELL |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$560 | 30 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
16 analysts |
$313 | 51 HOLD |
|
VERA
Vera Therapeutics Inc |
STRONG BUY
14 analysts |
$77 | 57 HOLD |
